Medtronic on Tuesday missed Wall Street estimates for third-quarter revenue due to lower purchases of its surgical devices by ...
Medtronic PLC (MDT) reports robust revenue and EPS growth, driven by innovations in Cardiac Ablation and Leadless Pacing, ...
Medtronic plc (NYSE:MDT – Get Free Report) shares were up 0.3% on Thursday after UBS Group raised their price target on the stock from $85.00 to $95.00. UBS Group currently has a neutral rating on the ...
Medtronic's stock has been static, not delivering any gains for investors. Click here to find out why MDT stock is a Buy.
Medtronic beat Wall Street estimates for third-quarter profit on Tuesday, partly helped by demand for its diabetes devices, ...
Shares of Medtronic PLC MDT advanced 1.08% to $87.94 Thursday, on what proved to be an all-around rough trading session for ...
Medtronic (NYSE:MDT – Get Free Report) had its target price raised by equities researchers at Robert W. Baird from $90.00 to $91.00 in a note issued to investors on Wednesday,Benzinga reports. The ...
Truist raised the firm’s price target on Medtronic (MDT) to $93 from $89 and keeps a Hold rating on the shares after its Q3 earnings beat.
In an “urgent medical device correction,” the company urges clinicians to remind patients to monitor their glucose levels during takeoffs and landings.
22h
GlobalData on MSNMedtronic launches spinal system for deformity proceduresGlobal healthcare technology developer Medtronic has launched the CD Horizon ModuLeX spinal system for deformity procedures, ...
Goldman Sachs analyst David Roman raised the firm’s price target on Medtronic (MDT) to $85 from $83 and keeps a Sell rating on the shares. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results